Maria C. Melander

759 total citations
18 papers, 584 citations indexed

About

Maria C. Melander is a scholar working on Oncology, Cancer Research and Immunology and Allergy. According to data from OpenAlex, Maria C. Melander has authored 18 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Cancer Research and 5 papers in Immunology and Allergy. Recurrent topics in Maria C. Melander's work include Protease and Inhibitor Mechanisms (9 papers), Cell Adhesion Molecules Research (5 papers) and Peptidase Inhibition and Analysis (4 papers). Maria C. Melander is often cited by papers focused on Protease and Inhibitor Mechanisms (9 papers), Cell Adhesion Molecules Research (5 papers) and Peptidase Inhibition and Analysis (4 papers). Maria C. Melander collaborates with scholars based in Denmark, United States and Norway. Maria C. Melander's co-authors include Lars H. Engelholm, Niels Behrendt, Henrik J. Jürgensen, Daniel H. Madsen, Signe Ingvarsen, Thomas Bugge, Henrik Gårdsvoll, Andreas Hald, Andreas Kjær and László Patthy and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Maria C. Melander

18 papers receiving 576 citations

Peers

Countries citing papers authored by Maria C. Melander

Since Specialization

Citations

This map shows the geographic impact of Maria C. Melander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria C. Melander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria C. Melander more than expected).

Fields of papers citing papers by Maria C. Melander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria C. Melander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria C. Melander. The network helps show where Maria C. Melander may publish in the future.

Co-authorship network of co-authors of Maria C. Melander

This figure shows the co-authorship network connecting the top 25 collaborators of Maria C. Melander. A scholar is included among the top collaborators of Maria C. Melander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria C. Melander. Maria C. Melander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Abstract LB220: S095029: a novel clinical-stage Fc-silenced NKG2A-blocking antibody with best-in-class potential 2023 ·Cancer Research ·Maria C. Melander, Bruno Laugel	2
2	Abstract 1797: Preclinical characterization of Sym024, a novel anti-CD73 antibody 2021 ·Cancer Research ·Janus S. Jakobsen, Matteo Riva, Maria C. Melander, (unknown), Klaus F. Kofoed, Mikkel W. Pedersen, Jutta Deckert, Lene Hansen, (unknown), Johan Lantto, Camilla Fröhlich, Michael M. Grandal	2
3	Tumor cell MT1-MMP is dispensable for osteosarcoma tumor growth, bone degradation and lung metastasis 2020 ·Scientific Reports ·Signe Ingvarsen, Henrik Gårdsvoll, Sander van Putten, (unknown), (unknown), (unknown), (unknown), Henrik J. Jürgensen, Maria C. Melander, Carsten H. Nielsen, Andreas Kjær, Thomas Bugge, Lars H. Engelholm, Niels Behrendt	15
4	Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform 2019 ·mAbs ·Torben Gjetting, Monika Gad, Camilla Fröhlich, Trine Lindsted, Maria C. Melander, Vikram Bhatia, Michael M. Grandal, Nikolaj Dietrich, Franziska Uhlenbrock, Gunther R. Galler, Magnus Strandh, Johan Lantto, Thomas Bouquin, Ivan D. Horak, Michael Kragh, Mikkel W. Pedersen, Klaus Koefoed	25
5	CD4⁺ and CD8a⁺ PET imaging predicts response to novel PD-1 checkpoint inhibitor: studies of Sym021 in syngeneic mouse cancer models 2019 ·Theranostics ·Lotte K. Kristensen, Camilla Fröhlich, Camilla L. Christensen, Maria C. Melander, Thomas T. Poulsen, Gunther R. Galler, Johan Lantto, Ivan D. Horak, Michael Kragh, Carsten H. Nielsen, Andreas Kjær	66
6	A phase I study of Sym021, an anti-PD-1 antibody (Ab), alone and in combination with Sym022 (anti-LAG-3) or Sym023 (anti-TIM-3) 2019 ·Annals of Oncology ·Anna Spreafico, Filip Jankú, (unknown), A. W. Tolcher, Sreenivasa R Chandana, Marc Oliva, (unknown), (unknown), Michael Kragh, (unknown), Camilla Fröhlich, Maria C. Melander, Thórarinn Blöndal, Mikkel W. Pedersen, Johan Lantto, Debra L. Wood, Paul I. Nadler, Ivan D. Horak, Lillian L. Siu, Nehal J. Lakhani	11
7	Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models 2018 ·Journal of Neuro-Oncology ·Stephen T. Keir, Vidyalakshmi Chandramohan, (unknown), Michael M. Grandal, Maria C. Melander, Mikkel W. Pedersen, Ivan D. Horak, Michael Kragh, Annick Desjardins, Henry S. Friedman, Darell D. Bigner	7
8	Abstract 5626: Preclinical characterization of Sym022, a novel anti-LAG3 antibody 2018 ·Cancer Research ·Michael M. Grandal, Maria C. Melander, Vikram Bhatia, Torben Gjetting, Trine Lindsted, Camilla Fröhlich, Johan Lantto, Ivan D. Horak, Michael Kragh, Klaus F. Kofoed, Mikkel W. Pedersen	8
9	The collagen receptor uPARAP/Endo180 as a novel target for antibody-drug conjugate mediated treatment of mesenchymal and leukemic cancers 2017 ·Oncotarget ·(unknown), (unknown), Ida Katrine Lund, Maria C. Melander, (unknown), Henrik J. Jürgensen, Kristian Reckzeh, (unknown), Signe Ingvarsen, Henrik Gårdsvoll, Kamilla E. Jensen, Petra Hamerlik, Lars H. Engelholm, Niels Behrendt	24
10	The collagen receptor uPARAP/Endo180 in tissue degradation and cancer (Review) 2015 ·International Journal of Oncology ·Maria C. Melander, Henrik J. Jürgensen, Daniel H. Madsen, Lars H. Engelholm, Niels Behrendt	57
11	Targeting a novel bone degradation pathway in primary bone cancer by inactivation of the collagen receptor uPARAP/Endo180 2015 ·The Journal of Pathology ·Lars H. Engelholm, Maria C. Melander, Andreas Hald, Morten Persson, Daniel H. Madsen, Henrik J. Jürgensen, Kristina Johansson, (unknown), (unknown), Signe Ingvarsen, Andreas Kjær, Clement Trovik, Ole Didrik Lærum, Thomas Bugge, Johan Eide, Niels Behrendt	23
12	Complex Determinants in Specific Members of the Mannose Receptor Family Govern Collagen Endocytosis 2014 ·Journal of Biological Chemistry ·Henrik J. Jürgensen, Kristina Johansson, Daniel H. Madsen, (unknown), Maria C. Melander, (unknown), (unknown), Thomas Bugge, Niels Behrendt, Lars H. Engelholm	42
13	Targeting a Single Function of the Multifunctional Matrix Metalloprotease MT1-MMP 2013 ·Journal of Biological Chemistry ·Signe Ingvarsen, (unknown), Charlotte Erpicum, (unknown), Henrik J. Jürgensen, Daniel H. Madsen, Maria C. Melander, Henrik Gårdsvoll, Gunilla Høyer‐Hansen, Agnès Noël, Kenn Holmbeck, Lars H. Engelholm, Niels Behrendt	48
14	Differential Actions of the Endocytic Collagen Receptor uPARAP/Endo180 and the Collagenase MMP-2 in Bone Homeostasis 2013 ·PLoS ONE ·Daniel H. Madsen, Henrik J. Jürgensen, Signe Ingvarsen, Maria C. Melander, Reidar Albrechtsen, Andreas Hald, Kenn Holmbeck, Thomas Bugge, Niels Behrendt, Lars H. Engelholm	27
15	Endocytic collagen degradation: a novel mechanism involved in protection against liver fibrosis 2012 ·The Journal of Pathology ·Daniel H. Madsen, Henrik J. Jürgensen, Signe Ingvarsen, Maria C. Melander, Ben Vainer, Kristoffer L. Egerod, Andreas Hald, Birgitte Rønø, (unknown), Thomas Bugge, Lars H. Engelholm, Niels Behrendt	44
16	A Novel Functional Role of Collagen Glycosylation 2011 ·Journal of Biological Chemistry ·Henrik J. Jürgensen, Daniel H. Madsen, Signe Ingvarsen, Maria C. Melander, Henrik Gårdsvoll, László Patthy, Lars H. Engelholm, Niels Behrendt	72
17	The Non-phagocytic Route of Collagen Uptake 2011 ·Journal of Biological Chemistry ·Daniel H. Madsen, Signe Ingvarsen, Henrik J. Jürgensen, Maria C. Melander, Lars Kjøller, Amanda Moyer, Christian Honoré, (unknown), Peter Garred, Sven Burgdorf, Thomas Bugge, Niels Behrendt, Lars H. Engelholm	99
18	MMP9 is protective against lethal inflammatory mass lesions in the mouse colon 2010 ·Disease Models & Mechanisms ·Andreas Hald, Birgitte Rønø, Maria C. Melander, Ming Ding, Susanne Holck, Leif R. Lund	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact